For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
After finishing at $2.66 in the prior trading day, Helius Medical Technologies Inc (NASDAQ: HSDT) closed at $2.87, up 7.89%. In other words, the price has increased by $7.89 from its previous closing price. On the day, 12.24 million shares were traded. HSDT stock price reached its highest trading level at $3.61 during the session, while it also had its lowest trading level at $2.35.
Ratios:
Our goal is to gain a better understanding of HSDT by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.64 and its Current Ratio is at 3.88. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Noble Capital Markets on March 24, 2021, initiated with a Outperform rating and assigned the stock a target price of $20.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 14 ’23 when ANDREEFF DANE bought 5,000 shares for $8.10 per share. The transaction valued at 40,475 led to the insider holds 16,512 shares of the business.
ANDREEFF DANE bought 2,006 shares of HSDT for $12,935 on Dec 01 ’23. The President and CEO now owns 13,685 shares after completing the transaction at $6.45 per share. On Nov 30 ’23, another insider, ANDREEFF DANE, who serves as the President and CEO of the company, bought 2,000 shares for $6.37 each. As a result, the insider paid 12,741 and bolstered with 12,551 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HSDT now has a Market Capitalization of 2546536 and an Enterprise Value of -2578463. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.99 while its Price-to-Book (P/B) ratio in mrq is 0.87. Its current Enterprise Value per Revenue stands at -4.004 whereas that against EBITDA is 0.213.
Stock Price History:
The Beta on a monthly basis for HSDT is 1.74, which has changed by -0.6695652 over the last 52 weeks, in comparison to a change of 0.22379243 over the same period for the S&P500. Over the past 52 weeks, HSDT has reached a high of $14.44, while it has fallen to a 52-week low of $2.50. The 50-Day Moving Average of the stock is -47.01%, while the 200-Day Moving Average is calculated to be -59.94%.
Shares Statistics:
The stock has traded on average 416.87K shares per day over the past 3-months and 34990 shares per day over the last 10 days, according to various share statistics. A total of 0.89M shares are outstanding, with a floating share count of 0.85M. Insiders hold about 4.62% of the company’s shares, while institutions hold 7.99% stake in the company. Shares short for HSDT as of 1713139200 were 72107 with a Short Ratio of 0.17, compared to 1710460800 on 111764. Therefore, it implies a Short% of Shares Outstanding of 72107 and a Short% of Float of 9.0100005.
Earnings Estimates
The company has 2.0 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$3.87 for the current quarter, with a high estimate of -$2.7 and a low estimate of -$5.04, while EPS last year was -$4.5. The consensus estimate for the next quarter is -$2.25, with high estimates of -$2.04 and low estimates of -$2.47.
Analysts are recommending an EPS of between -$8.58 and -$12.43 for the fiscal current year, implying an average EPS of -$10.5. EPS for the following year is -$5.45, with 2.0 analysts recommending between -$2.06 and -$8.85.
Revenue Estimates
For the next quarter, 2 analysts are estimating revenue of $160k. There is a high estimate of $190k for the next quarter, whereas the lowest estimate is $120k.
A total of 2 analysts have provided revenue estimates for HSDT’s current fiscal year. The highest revenue estimate was $1.3M, while the lowest revenue estimate was $650k, resulting in an average revenue estimate of $980k. In the same quarter a year ago, actual revenue was $644kBased on 2 analysts’ estimates, the company’s revenue will be $5.06M in the next fiscal year. The high estimate is $8.8M and the low estimate is $1.31M.
